Acquirer
Revvity, Inc.
Revvity, Inc. appears as the named buyer in 5 recorded transactions between 2014 and 2021, most often in healthcare & life sciences and software & internet. 2 of those were bought from a private equity seller, which makes this a buyer that funds in the sector actually exit to.
Record
What Revvity, Inc. has bought
Every recorded transaction where Revvity, Inc. is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Immunodiagnostic Systems | Healthcare & Life Sciences | — | 2021-05-17 | $155m |
| Nexcelom Bioscience | Healthcare & Life Sciences | Ampersand Capital Partners PE | 2021-05-12 | $260m |
| Oxford Immunotec Global PLC | Healthcare & Life Sciences | — | 2021-01-07 | $591m |
| Horizon Discovery Group PLC | Healthcare & Life Sciences | — | 2020-11-02 | $456m |
| Perten Instruments Group AB | Software & Internet | Valedo Partners PE | 2014-11-24 | $266m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.